Cynata's technology came about after bone-marrow derived technologies, so naturally they are not as far down the road, relatively speaking. However, it doesn't mean that Cynata will not continue to advance the technology in a clinical setting and increase the value in the short and long term.
- Forums
- ASX - By Stock
- CYP
- Ann: Investor Presentation
CYP
cynata therapeutics limited
Add to My Watchlist
8.82%
!
15.5¢

Ann: Investor Presentation, page-255
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
15.5¢ |
Change
-0.015(8.82%) |
Mkt cap ! $35.02M |
Open | High | Low | Value | Volume |
17.0¢ | 17.0¢ | 15.5¢ | $35.01K | 213.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 201289 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 14675 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12458 | 0.160 |
4 | 201289 | 0.155 |
8 | 423545 | 0.150 |
4 | 81775 | 0.145 |
4 | 29291 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 15000 | 1 |
0.165 | 14675 | 1 |
0.170 | 26942 | 1 |
0.175 | 54733 | 2 |
0.180 | 167827 | 3 |
Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |